Cargando…
Can Body Mass Index Affect Height Growth at Menarche among Girls Receiving Treatment for Early Puberty? A Retrospective Study in Korean Girls
Gonadotropin-releasing hormone agonist (GnRHa) therapy is used to control puberty progression and it preserves height potential in patients with idiopathic central precocious puberty (ICPP). This study evaluated the correlation between weight and height gain at menarche following GnRHa treatment amo...
Autores principales: | Lee, Sun-Jin, Kim, Sun-Young, Kim, Minsun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774609/ https://www.ncbi.nlm.nih.gov/pubmed/35053736 http://dx.doi.org/10.3390/children9010110 |
Ejemplares similares
-
Trend of Menarcheal Age among Korean Girls
por: Seo, Moon Young, et al.
Publicado: (2020) -
Effects of Gonadotropin-Releasing Hormone Agonist Therapy on Body Mass Index and Height in Girls with Central Precocious Puberty
por: Lee, Seung Jae, et al.
Publicado: (2012) -
Relationship Between Body Mass Index and Early Menarche of Adolescent Girls in Seoul
por: Oh, Chang-Mo, et al.
Publicado: (2012) -
Age at menarche and near final height after treatment with
gonadotropin-releasing hormone agonist alone or combined with growth hormone in Korean
girls with central precocious puberty
por: Gyon, YunHee, et al.
Publicado: (2015) -
Urinary mycoestrogens and age and height at menarche in New Jersey girls
por: Rivera-Núñez, Zorimar, et al.
Publicado: (2019)